1-4 of 4
M Fey
Close
Sort by
Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

C. Kelaidi, L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton, E. Raffoux, C. Rayon, J. de la Serna, A. Ferrant, D. Bron, H. Link, N. Fegueux, D. Bordessoule, F. Rigal-Huguet, A.M. Stoppa, A. Vekhoff, S. Meyer-Monard, M. Fey, S. Castaigne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 890.
https://doi.org/10.1182/blood.V106.11.890.890
Published: 2005
Journal Articles

Relationship Between Cleaved L-Selectin Levels and the Outcome of Acute Myeloid Leukemia

M. Extermann, M. Bacchi, N. Monai, M. Fopp, M. Fey, A. Tichelli, M. Schapira, O. Spertini
Journal: Blood
Blood (1998) 92 (9): 3115–3122.
https://doi.org/10.1182/blood.V92.9.3115
Published: 1998
Journal Articles

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]

P Fenaux, E Wattel, E Archimbaud, M Sanz, B Hecquet, N Fegueux, A Guerci, H Link, M Fey, S Castaigne
Journal: Blood
Blood (1994) 84 (2): 666–667.
https://doi.org/10.1182/blood.V84.2.666.666
Published: 1994
Journal Articles

High-dose cytosine arabinoside therapy for refractory leukemia [letter]

M Fey
Journal: Blood
Blood (1984) 64 (3): 758–759.
https://doi.org/10.1182/blood.V64.3.758a.758a
Published: 1984